Published in Vaccine Weekly, May 10th, 1999
The study, conducted in 1994 during a serogroup B meningococcal disease epidemic in Santiago, Chile, tested two similar vaccines made in Cuba and Norway. Both vaccines were derived from the outer membrane protein (OMP) of Neisseria meningitidis. The vaccines were made from bacterial strains that did not exactly match the epidemic strain.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly